Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma

  1. Morante, M.
  2. Pandiella, A.
  3. Crespo, P.
  4. Herrero, A.
Zeitschrift:
Biomolecules

ISSN: 2218-273X

Datum der Publikation: 2022

Ausgabe: 12

Nummer: 11

Art: Rezension

DOI: 10.3390/BIOM12111562 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus